Literature DB >> 1423818

Non-tissue factor procoagulants in cancer cells.

S G Gordon1, M Chelladurai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1423818     DOI： 10.1007/bf01307182

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN： 0167-7659            Impact factor:   9.264


× No keyword cloud information.
  140 in total

1.  WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

Authors:  E W DAVIE; O D RATNOFF
Journal:  Science       Date:  1964-09-18       Impact factor: 47.728

2.  [Effect of sequential MTX/5-FU therapy for a case of disseminated intravascular coagulation syndrome associated with recurrence of gastric cancer--a case report].

Authors:  H Koike; T Konishi; K Mafune; T Hirata; T Miyama; M Hiraishi; Y Idezuki
Journal:  Nihon Geka Gakkai Zasshi       Date:  1989-07

3.  Aspirin and tumour metastasis.

Authors:  S Wood; P Hilgard
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

4.  Anticoagulant properties of bovine plasma protein C following activation by thrombin.

Authors:  W Kisiel; W M Canfield; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1977-12-27       Impact factor: 3.162

5.  A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis.

Authors:  D G Menter; B W Steinert; B F Sloane; J D Taylor; K V Honn
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

Review 6.  Antimetastatic agents. I. Role of cellular procoagulants in the pathogenesis of fibrin deposition in cancer and the use of anticoagulants and/or antiplatelet drugs in cancer treatment.

Authors:  F R Rickles; W W Hancock; R L Edwards; L R Zacharski
Journal:  Semin Thromb Hemost       Date:  1988-01       Impact factor: 4.180

7.  Thromboxanes and prostacyclin: positive and negative modulators of tumor growth.

Authors:  K V Honn; J Meyer
Journal:  Biochem Biophys Res Commun       Date:  1981-10-30       Impact factor: 3.575

8.  Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression.

Authors:  H F Dvorak; A M Dvorak; E J Manseau; L Wiberg; W H Churchill
Journal:  J Natl Cancer Inst       Date:  1979-06       Impact factor: 13.506

9.  The site of activation of factor X by cancer procoagulant.

Authors:  S G Gordon; A M Mourad
Journal:  Blood Coagul Fibrinolysis       Date:  1991-12       Impact factor: 1.276

10.  Reduced generation of procoagulant activity by endotoxin-stimulated mononuclear cells from patients with chronic myeloid leukaemia.

Authors:  S Cortellazzo; P Viero; T Barbui; M Colucci; N Semeraro
Journal:  Br J Haematol       Date:  1981-07       Impact factor: 6.998
View more
  2 in total

Review 1.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 2.  Platelets and cancer: a casual or causal relationship: revisited.

Authors:  David G Menter; Stephanie C Tucker; Scott Kopetz; Anil K Sood; John D Crissman; Kenneth V Honn
Journal:  Cancer Metastasis Rev       Date:  2014-03       Impact factor: 9.264
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.